Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:1732-1740
Published online before print May 24, 2007, doi: 10.1161/CIRCRESAHA.107.148791
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/12/1732    most recent
CIRCRESAHA.107.148791v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santini, M. P.
Right arrow Articles by Rosenthal, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santini, M. P.
Right arrow Articles by Rosenthal, N.
Related Collections
Right arrow Remodeling
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Heart failure - basic studies
(Circulation Research. 2007;100:1732.)
© 2007 American Heart Association, Inc.


Integrative Physiology

Enhancing Repair of the Mammalian Heart

Maria Paola Santini, Lana Tsao, Laurent Monassier, Catherine Theodoropoulos, Janice Carter, Enrique Lara-Pezzi, Esfir Slonimsky, Ekaterina Salimova, Patrice Delafontaine, Yao-Hua Song, Martin Bergmann, Christian Freund, Ken Suzuki, Nadia Rosenthal

From the European Molecular Biology Laboratory (M.P.S., J.C., E.L.-P., E. Slonimsky, E. Salimova, N.R.), Mouse Biology Unit Monterotondo (Rome), Italy; Beth Israel Deaconess Medical Center, Cardiovascular Division (L.T.), Boston, Mass; Mouse Clinical Institute (L.M.), Illkirch Cedex, France; VisualSonics Inc (C.T.), Toronto, Ontario, Canada; Tulane University Health Sciences Center, Section of Cardiology (P.D., Y.-H.S.), New Orleans, La; Franz Volhart Clinic at MDC (M.B., C.F.), Charite’ Campus Buch, University Medicine Berlin, Germany; Harefield Heart Science Centre (K.S.), Imperial College London, UK; and the University of Cambridge (J.C.), Addenbrookes Hospital, Cambridge, UK.

Correspondence to Nadia Rosenthal, Mouse Biology Unit Monterotondo, Rome, Italy. E-mail rosenthal{at}embl.it

The injured mammalian heart is particularly susceptible to tissue deterioration, scarring, and loss of contractile function in response to trauma or sustained disease. We tested the ability of a locally acting insulin-like growth factor-1 isoform (mIGF-1) to recover heart functionality, expressing the transgene in the mouse myocardium to exclude endocrine effects on other tissues. supplemental mIGF-1 expression did not perturb normal cardiac growth and physiology. Restoration of cardiac function in post-infarct mIGF-1 transgenic mice was facilitated by modulation of the inflammatory response and increased antiapoptotic signaling. mIGF-1 ventricular tissue exhibited increased proliferative activity several weeks after injury. The canonical signaling pathway involving Akt, mTOR, and p70S6 kinase was not induced in mIGF-1 hearts, which instead activated alternate PDK1 and SGK1 signaling intermediates. The robust response achieved with the mIGF-1 isoform provides a mechanistic basis for clinically feasible therapeutic strategies for improving the outcome of heart disease.


Key Words: cardiac muscle • insulin-like growth factor-1 • regeneration • wound healing




This article has been cited by other articles:


Home page
CirculationHome page
D. P. Del Re and J. Sadoshima
Optimizing Cell-Based Therapy for Cardiac Regeneration
Circulation, September 8, 2009; 120(10): 831 - 834.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G. P. Meyer, A. Ganser, H. Drexler, and K. C. Wollert
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction
Eur. Heart J., December 1, 2008; 29(23): 2851 - 2858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Semenova, H. Koegel, S. Hasse, J. E. Klatte, E. Slonimsky, D. Bilbao, R. Paus, S. Werner, and N. Rosenthal
Overexpression of mIGF-1 in Keratinocytes Improves Wound Healing and Accelerates Hair Follicle Formation and Cycling in Mice
Am. J. Pathol., November 1, 2008; 173(5): 1295 - 1310.
[Abstract] [Full Text] [PDF]